CTRI/2017/09/009673
Completed
Phase 4
Comparison of anti-platelet efficacy of four different marketed formulations of Aspirin in diabetic patients.
Dr Kanharam Patel0 sites121 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Patients with Type 2 DM receiving oral anti-diabetic and who have two or more risk factors for cardiovascular disease
- Sponsor
- Dr Kanharam Patel
- Enrollment
- 121
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with Type 2 DM receiving oral anti\-diabetic with dietary modifications and who have two or more risk factors for cardiovascular disease.
Exclusion Criteria
- •Patients having age \<40 yrs.
- •Uncontrolled diabetes mellitus (Fasting BSL \> 300 mg/dL Despite therapy)
- •Uncontrolled Hypertension
- •Abnormal Liver Function Tests and/or Renal Function Tests.
- •Patients receiving any form or dose of Aspirin therapy for \>7 days
- •Patient receiving any other antithrombotic or anti\-coagulant therapy.
- •Patients having deranged bleeding and/ or clotting time at baseline study.
- •Patient on insulin.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Evaluation of antiplatelet effects of different dosages of aspirin in type 2 diabetic patients.Patients with type 2 diabetes mellitus with an indication for aspirin treatment or already on aspirin treatment.EUCTR2007-003186-40-SEKarolinska Institute30
Terminated
Not Applicable
Comparison of the effect of an anti-platelet intervention with Ticagrelor versus placebo on participants with asymptomatic elevations in troponin TACTRN12614000189628Professor Derek Chew420
Recruiting
Not Applicable
Study on the responsiveness of antiplatelet drugs in patients with cerebral infarction.oncardioembolic ischemic strokeJPRN-UMIN000005997Keio University School of Medicine Department of Neurology200
Completed
Phase 3
Comparison of the efficacy of platelet-rich plasma injection and conventional steroid injection for pain relief and functional improvement of partial supraspinatus tearssupraspinatous tearPlatelet rich plasma,Supraspinatous tear,rotator cuff tear,Pain interventionTCTR20200805007faculty of medicine, Chulalongkorn University32
Completed
Not Applicable
DACAB Trial: Follow-up ExtensionCoronary Artery Bypass GraftingAntiplatelet TherapyNCT03987373Ruijin Hospital500